Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Anavex Life Sciences Corp AVXL

Healthcare Biotechnology
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of... see more

Recent & Breaking News (NDAQ:AVXL)

Anavex raises $2.6-million in private placement and conversion of liabilities, enters into $10-million financing commitment and appoints CEO

PR Newswire July 8, 2013

Anavex Comments on Recent Stock Volume and Price Increase

Marketwired June 12, 2013

Anavex Comments on Recent Stock Volume and Price Increase

Marketwired June 12, 2013

PremierEquityReports.com Adds Creative Edge Nutrition Inc. (PINKSHEETS: FITX), Biozoom Inc. (OTCQB: BIZM), and Anavex Life Sciences Corp. (OTCQB: AVXL) to Watch List: Provides Update on Aristocrat Group Inc. (OTCQB: ASCC)

Marketwired June 5, 2013

Anavex invited to file funding application for Phase 2a clinical trial of ANAVEX 2-73

PR Newswire May 6, 2013

Anavex comments on FDA plan to expedite approval of new Alzheimer's drugs

PR Newswire March 18, 2013

ANAVEX 2-73 restores mitochondrial functionality, blocks cell death and oxidative stress, preventing onset of Alzheimer's disease

PR Newswire March 12, 2013

Anavex retains Novak Druce Connolly Bove & Quigg to maximize value of intellectual property portfolio

PR Newswire February 4, 2013

Anavex appoints Tom Skarpelos as Director

PR Newswire January 10, 2013